// App-Quantinova.ai

: A Clinical‐genetic Risk Score to Predict Cancer‐associated Venous Thromboembolism: A Development and Validation Study in Two Independent Prospective Cohorts

Researchers

Presenter

  • A. Muoz

Principal Investigators

  • C. Ay

  • E. Gritz

  • S. Lopez

  • C. Font

  • V. Pachon

  • V. Castellon

  • V. Martinez-Marin

  • M. Salgado

  • E. Martinez

  • J. Calzas

  • A. Ruperez

  • E. Salas

  • I. Pabinger

  • J.M. Soria

Medical Centers

  • Medical Oncology Service, Hospital General Universitario Gregorio Maranon, Madrid, Spain

  • Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

  • Genomic of Complex Diseases. Biomedical Research Institute Sant Pau IIB‐Sant Pau, Barcelona, Spain

  • Cancer and Thrombosis Working Group, Spanish Society of Medical Oncology SEOM, Madrid, Spain, 5Cancer and Thrombosis Working Group, Spanish Society of Medical Oncology SEOM, Madrid, Spain

  • Genomic of Complex Diseases. Biomedical Research Institute Sant Pau IIB‐Sant Pau, Barcelona, Spain

Locations

  • Spain

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Hypertension

  • Diabetes

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved